Wendy M. Macfarlane

2.3k total citations
42 papers, 1.7k citations indexed

About

Wendy M. Macfarlane is a scholar working on Surgery, Molecular Biology and Genetics. According to data from OpenAlex, Wendy M. Macfarlane has authored 42 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Surgery, 19 papers in Molecular Biology and 12 papers in Genetics. Recurrent topics in Wendy M. Macfarlane's work include Pancreatic function and diabetes (27 papers), Metabolism, Diabetes, and Cancer (14 papers) and Diabetes and associated disorders (6 papers). Wendy M. Macfarlane is often cited by papers focused on Pancreatic function and diabetes (27 papers), Metabolism, Diabetes, and Cancer (14 papers) and Diabetes and associated disorders (6 papers). Wendy M. Macfarlane collaborates with scholars based in United Kingdom, South Africa and United States. Wendy M. Macfarlane's co-authors include Kevin Docherty, Roger F.L. James, Susan C. Campbell, Helen Cragg, Jonathan Nzakizwanayo, Brian V. Jones, Caroline M. McKinnon, Zoë A. Felton-Edkins, Martin L. Read and Gary Phillips and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and PLoS ONE.

In The Last Decade

Wendy M. Macfarlane

42 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wendy M. Macfarlane United Kingdom 23 1.1k 816 628 432 116 42 1.7k
Gina R. Rayat Canada 24 1.1k 1.0× 285 0.3× 556 0.9× 199 0.5× 27 0.2× 69 1.7k
Jorge Berlanga‐Acosta Cuba 18 253 0.2× 277 0.3× 212 0.3× 471 1.1× 37 0.3× 44 1.4k
Simranjeet Kaur Denmark 18 252 0.2× 555 0.7× 250 0.4× 146 0.3× 34 0.3× 58 1.2k
Robert C. De Lisle United States 28 680 0.6× 953 1.2× 292 0.5× 80 0.2× 235 2.0× 63 2.4k
Manuela Carvalheiro Portugal 18 200 0.2× 292 0.4× 141 0.2× 236 0.5× 34 0.3× 99 1.2k
Claire B. Larmonier United States 24 213 0.2× 674 0.8× 306 0.5× 47 0.1× 36 0.3× 36 2.0k
Xueling Li China 19 375 0.4× 688 0.8× 200 0.3× 95 0.2× 38 0.3× 49 1.1k
Shu Li China 24 177 0.2× 914 1.1× 101 0.2× 101 0.2× 73 0.6× 86 1.8k
Feng Zhu China 23 202 0.2× 948 1.2× 121 0.2× 86 0.2× 54 0.5× 62 1.7k

Countries citing papers authored by Wendy M. Macfarlane

Since Specialization
Citations

This map shows the geographic impact of Wendy M. Macfarlane's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wendy M. Macfarlane with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wendy M. Macfarlane more than expected).

Fields of papers citing papers by Wendy M. Macfarlane

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wendy M. Macfarlane. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wendy M. Macfarlane. The network helps show where Wendy M. Macfarlane may publish in the future.

Co-authorship network of co-authors of Wendy M. Macfarlane

This figure shows the co-authorship network connecting the top 25 collaborators of Wendy M. Macfarlane. A scholar is included among the top collaborators of Wendy M. Macfarlane based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wendy M. Macfarlane. Wendy M. Macfarlane is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wand, Matthew E., et al.. (2024). Identification of mechanisms modulating chlorhexidine and octenidine susceptibility inProteus mirabilis. Journal of Applied Microbiology. 135(7). 2 indexed citations
2.
Macfarlane, Wendy M., Gary Phillips, Andrew W. Lloyd, et al.. (2019). Predicting pharmacokinetic behaviour of drug release from drug-eluting embolization beads using in vitro elution methods. European Journal of Pharmaceutical Sciences. 136. 104943–104943. 26 indexed citations
3.
Phillips, Gary, et al.. (2017). Preparation and characterisation of vandetanib-eluting radiopaque beads for locoregional treatment of hepatic malignancies. European Journal of Pharmaceutical Sciences. 101. 22–30. 25 indexed citations
4.
Bowyer, Cressida, Andrew L. Lewis, Andrew W. Lloyd, Gary Phillips, & Wendy M. Macfarlane. (2017). Hypoxia as a target for drug combination therapy of liver cancer. Anti-Cancer Drugs. 28(7). 771–780. 28 indexed citations
5.
Kumar, Sandeep, et al.. (2017). The role of tumour suppressor PDCD4 in beta cell death in hypoxia. PLoS ONE. 12(7). e0181235–e0181235. 4 indexed citations
6.
Nzakizwanayo, Jonathan, Sandeep Kumar, Lesley A. Ogilvie, et al.. (2015). Disruption of Escherichia coli Nissle 1917 K5 Capsule Biosynthesis, through Loss of Distinct kfi genes, Modulates Interaction with Intestinal Epithelial Cells and Impact on Cell Health. PLoS ONE. 10(3). e0120430–e0120430. 19 indexed citations
7.
Tang, Yiqing, Cressida Bowyer, Andrew W. Lloyd, et al.. (2012). Development of a combination drug-eluting bead. Anti-Cancer Drugs. 23(4). 355–369. 16 indexed citations
8.
Thürmer, F., Christine Wallrapp, Andrew W. Lloyd, et al.. (2010). Characterisation of physico-mechanical properties and degradation potential of calcium alginate beads for use in embolisation. Journal of Materials Science Materials in Medicine. 21(7). 2243–2251. 51 indexed citations
9.
10.
Campbell, Susan C., A Aldibbiat, Tomader Ali, et al.. (2008). Selenium stimulates pancreatic beta‐cell gene expression and enhances islet function. FEBS Letters. 582(15). 2333–2337. 52 indexed citations
11.
Ferris, William Frank, Lize van der Merwe, Susan C. Campbell, & Wendy M. Macfarlane. (2005). Glucocorticoid Administration and Brief Occlusion of the Main Pancreatic Duct Are Likely to Increase Islet Mass by a Similar Mechanism. Pancreas. 31(2). 132–137. 2 indexed citations
12.
Campbell, Susan C., et al.. (2004). Transcriptional regulation of the IAPP gene in pancreatic β-cells. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression. 1681(1). 28–37. 14 indexed citations
13.
Campbell, Susan C. & Wendy M. Macfarlane. (2003). Detection of Insulin Production by Immunohistochemistry. Diabetes Mellitus. 83. 47–49. 1 indexed citations
14.
Weng, Jianping, Wendy M. Macfarlane, Markku Lehto, et al.. (2001). Functional consequences of mutations in the MODY4 gene (IPF1) and coexistence with MODY3 mutations. Diabetologia. 44(2). 249–258. 50 indexed citations
15.
Macfarlane, Wendy M., Susan C. Campbell, Lucy J. Elrick, et al.. (2000). Glucose Regulates Islet Amyloid Polypeptide Gene Transcription in a PDX1- and Calcium-dependent Manner. Journal of Biological Chemistry. 275(20). 15330–15335. 57 indexed citations
16.
Macfarlane, Wendy M., Timothy M. Frayling, Sian Ellard, et al.. (1999). Missense mutations in the insulin promoter factor-1 gene predispose to type 2 diabetes. Journal of Clinical Investigation. 104(9). R33–R39. 201 indexed citations
17.
Macfarlane, Wendy M., Ruth M. Shepherd, Noritaka Kamimura, et al.. (1999). Engineering a Glucose-responsive Human Insulin-secreting Cell Line from Islets of Langerhans Isolated from a Patient with Persistent Hyperinsulinemic Hypoglycemia of Infancy. Journal of Biological Chemistry. 274(48). 34059–34066. 50 indexed citations
18.
Campbell, Susan C., Helen Cragg, Lucy J. Elrick, et al.. (1999). Inhibitory effect of Pax4 on the human insulin and islet amyloid polypeptide (IAPP) promoters. FEBS Letters. 463(1-2). 53–57. 35 indexed citations
19.
Macfarlane, Wendy M., Stuart B. Smith, Roger F.L. James, et al.. (1997). The p38/Reactivating Kinase Mitogen-activated Protein Kinase Cascade Mediates the Activation of the Transcription Factor Insulin Upstream Factor 1 and Insulin Gene Transcription by High Glucose in Pancreatic β-Cells. Journal of Biological Chemistry. 272(33). 20936–20944. 150 indexed citations
20.
Macfarlane, Wendy M., Helen Cragg, Hilary M. Docherty, et al.. (1997). Impaired expression of transcription factor IUF1 in a pancreatic β‐cell line derived from a patient with persistent hyperinsulinaemic hypoglycaemia of infancy (nesidioblastosis). FEBS Letters. 413(2). 304–308. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gina R. Rayat Breakdown of academic impact, for papers by Jorge Berlanga‐Acosta Breakdown of academic impact, for papers by Simranjeet Kaur Breakdown of academic impact, for papers by Robert C. De Lisle Breakdown of academic impact, for papers by Manuela Carvalheiro Breakdown of academic impact, for papers by Claire B. Larmonier Breakdown of academic impact, for papers by Xueling Li Breakdown of academic impact, for papers by Shu Li Breakdown of academic impact, for papers by Feng Zhu
Rankless by CCL
2026